Incomplete data present serious problems when integrating largescale brain imaging data sets from different imaging modalities. In the Alzheimer’s Disease Neuroimaging Initiativ...
Lei Yuan, Yalin Wang, Paul M. Thompson, Vaibhav A....
— We make use of discrete wavelets to extract distinguishing features between normal and cancerous human breast tissue fluorescence spectra. These are then used in conjunction wi...
Bhadra Mani, C. Raghavendra Rao, P. Anantha Lakshm...
Background: Recent advances in proteomics technologies such as SELDI-TOF mass spectrometry has shown promise in the detection of early stage cancers. However, dimensionality reduc...
Kai-Lin Tang, Tong-Hua Li, Wen-Wei Xiong, Kai Chen
Background: The reliable extraction of features from mass spectra is a fundamental step in the automated analysis of proteomic mass spectrometry (MS) experiments. Results: This co...
Bernhard Y. Renard, Marc Kirchner, Hanno Steen, Ju...
Background: The use of mass spectrometry as a proteomics tool is poised to revolutionize early disease diagnosis and biomarker identification. Unfortunately, before standard super...